Are you researching the medicinal properties of Cannabidiol (CBD) or other Cannabinoids?
The current resurgence of interest in Cannabinoids for use as pharmaceutical treatments had lead to an increase in demand for GMP-grade CBD. If you are investigating CBD as a potential therapeutic treatment for cancer, seizures, dermatological conditions, anxiety or other conditions Tepnel Pharma Services can support your quality control testing needs.
At Tepnel we have experience and capabilities in testing Cannabinoid formulations and hold schedules 1, 2, 3, 4 part I, 4 part II and schedule 5 controlled drugs licenses.
We can support your pharmaceutical research and development from preclinical enabling stability and formulation selection through to batch release testing into the marketplace.
With an emphasis on inhalation, oral dosage, parenteral and biologics, our full range of services include:
- Lot and batch release testing
- ICH stability testing and storage
- Raw materials testing
- Pharmacopeial testing
- ICH method development and validation
We are committed to providing laboratory services that deliver on the promise of quality. Through a highly skilled workforce and a customer-focused performance we will work alongside you towards a common goal.
Our cGMP pharmaceutical testing facility is located in Livingston, Scotland where we work together with our customers and partners building mutual trust through a sharing of knowledge, expertise and teamwork.
To find out how partnering with Tepnel can reduce cost and accelerate your Cannabinoid development programme please contact:
Business Development Manager
Mobile : +44 (0) 7785 438 308
Office : +44 (0) 1506 424 270